Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Dapagliflozin cuts HbA1c in paediatric T2D
17 Oct 2023
bởiElvira Manzano
Dapagliflozin reduced HbA1c by 1.03 percentage points more than placebo in children and adolescents with type 2 diabetes (T2D), while saxagliptin showed no significant reduction vs placebo in the phase III T2NOW trial presented at EASD 2023.
Dapagliflozin cuts HbA1c in paediatric T2D
17 Oct 2023Age, motion sickness tied to chemo-induced nausea, vomiting in children with cancer
11 Oct 2023
In children with cancer receiving chemotherapy, factors such as age and susceptibility to motion sickness are associated with the risk of acute chemotherapy-induced nausea (CIN), reports a study.